by Clinical Neuropsychologist Online | Saturday, August 3, 2024 | Dementia
Abstract INTRODUCTION We developed a multimarker blood test result interpretation tool for the clinical dementia practice, including phosphorylated (P-)tau181, amyloid-beta (Abeta)42/40, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL). METHODS We...
by Clinical Neuropsychologist Online | Saturday, August 3, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Timothy Daly, Kasper P. Kepp, Bruno P. Imbimbo | August 3, 2024...
by Clinical Neuropsychologist Online | Saturday, August 3, 2024 | Neuropsychology (general)
Volume 39, Issue 2, February 2025, Page 237-251. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Rebecca E. Ready Eleni Kapoulea Irina Orlovsky Maya Whaley...
by Clinical Neuropsychologist Online | Friday, August 2, 2024 | Dementia
Abstract INTRODUCTION Triggering receptor expressed on myeloid cells 2 (TREM2) agonists are being clinically evaluated as disease-modifying therapeutics for Alzheimer’s disease. Clinically translatable pharmacodynamic (PD) biomarkers are needed to confirm drug...
by Clinical Neuropsychologist Online | Friday, August 2, 2024 | Neuroscience
Nature Neuroscience, Published online: 02 August 2024; doi:10.1038/s41593-024-01724-1Studying GnRH neuroendocrine cells in the mouse olfactory bulb (GnRHOB neurons), Decoster et al. show that these cells respond to female odors and their activation regulates males’...
